Eevia Health Oyj Past Earnings Performance

Past criteria checks 0/6

Eevia Health Oyj's earnings have been declining at an average annual rate of -7.2%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been declining at an average rate of 5.2% per year.

Key information

-7.2%

Earnings growth rate

43.4%

EPS growth rate

Pharmaceuticals Industry Growth30.5%
Revenue growth rate-5.2%
Return on equity-93.9%
Net Margin-201.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Eevia Health Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:EEVIA Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241-310
30 Jun 242-210
31 Mar 244-110
31 Dec 235-120
30 Sep 236-130
30 Jun 236-130
31 Mar 236-130
31 Dec 226-230
30 Sep 225-230
30 Jun 226-330
31 Mar 225-320
31 Dec 217-330
30 Sep 218-220
30 Jun 217-220
31 Mar 216-120
31 Dec 203-110
31 Dec 191010
31 Dec 181-110
31 Dec 171-100

Quality Earnings: EEVIA is currently unprofitable.

Growing Profit Margin: EEVIA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EEVIA is unprofitable, and losses have increased over the past 5 years at a rate of 7.2% per year.

Accelerating Growth: Unable to compare EEVIA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EEVIA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (9.5%).


Return on Equity

High ROE: EEVIA has a negative Return on Equity (-93.89%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 17:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eevia Health Oyj is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution